Correlation Between Aadi Bioscience and Design Therapeutics
Can any of the company-specific risk be diversified away by investing in both Aadi Bioscience and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aadi Bioscience and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aadi Bioscience and Design Therapeutics, you can compare the effects of market volatilities on Aadi Bioscience and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aadi Bioscience with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aadi Bioscience and Design Therapeutics.
Diversification Opportunities for Aadi Bioscience and Design Therapeutics
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Aadi and Design is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Aadi Bioscience and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and Aadi Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aadi Bioscience are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of Aadi Bioscience i.e., Aadi Bioscience and Design Therapeutics go up and down completely randomly.
Pair Corralation between Aadi Bioscience and Design Therapeutics
Given the investment horizon of 90 days Aadi Bioscience is expected to generate 0.51 times more return on investment than Design Therapeutics. However, Aadi Bioscience is 1.98 times less risky than Design Therapeutics. It trades about 0.2 of its potential returns per unit of risk. Design Therapeutics is currently generating about 0.08 per unit of risk. If you would invest 177.00 in Aadi Bioscience on September 12, 2024 and sell it today you would earn a total of 65.00 from holding Aadi Bioscience or generate 36.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aadi Bioscience vs. Design Therapeutics
Performance |
| Timeline |
| Aadi Bioscience |
| Design Therapeutics |
Aadi Bioscience and Design Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aadi Bioscience and Design Therapeutics
The main advantage of trading using opposite Aadi Bioscience and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aadi Bioscience position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.| Aadi Bioscience vs. Anebulo Pharmaceuticals | Aadi Bioscience vs. Adagene | Aadi Bioscience vs. Acrivon Therapeutics, Common | Aadi Bioscience vs. AnaptysBio |
| Design Therapeutics vs. Monte Rosa Therapeutics | Design Therapeutics vs. Werewolf Therapeutics | Design Therapeutics vs. Ikena Oncology | Design Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |